Background Environmental enrichment training may delay cognitive decline in mild cognitive impairment (MCI) by reducing telomere shortening, a cellular marker of aging. We investigated whether combined physical/cognitive training affects leukocyte telomere length (LTL) in the randomized trial "Train the Brain". Methods LTL was assessed in 94 MCI (75.1 +/- 5.1 years) subjects and 37 non-MCI subjects (73.2 +/- 4.6 years). MCI patients were assigned to receive either 7 months of training or standard care. After 7 months, both groups were reassessed for changes in LTL and the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog). Telomerase reverse transcriptase (hTERT) mRNA and telomeric repeat-containing RNA (TERRA) were also tested in 24 patients. Results MCI patients had shorter LTL than controls (p = 0.02), and short LTL was associated with a higher risk of MCI (ORadjusted = 2.6; 95%CI, 1.1-6.0; p = 0.03). Training improved ADAS-cog scores (T-0 = 15.1 +/- 4.8 to T-7 = 13.4 +/- 5.0, p = 0.01) and increased LTL (T-0 = 0.97 +/- 0.21 to T-7 = 1.04 +/- 0.23, p = 0.04). hTERT mRNA levels were negligible in MCI patients at T0 and T7, indicating inactive telomerase. TERRA expression increased in untrained MCI (p = 0.02), which may reflect impaired telomere homeostasis. Conclusions MCI patients have shorter telomeres, and combined training lengthens them, suggesting modifiable telomere homeostasis through non-pharmacological intervention. Telomere shortening may underlie increased telomeric transcription in untrained individuals, highlighting telomeric non-coding RNAs as potential therapeutic targets in age-related disease.
Combined physical and cognitive training enhances telomere length in mild cognitive impairment patients
Canale, Paola;Sicari, Rosa;Andreassi, Maria Grazia
2026-01-01
Abstract
Background Environmental enrichment training may delay cognitive decline in mild cognitive impairment (MCI) by reducing telomere shortening, a cellular marker of aging. We investigated whether combined physical/cognitive training affects leukocyte telomere length (LTL) in the randomized trial "Train the Brain". Methods LTL was assessed in 94 MCI (75.1 +/- 5.1 years) subjects and 37 non-MCI subjects (73.2 +/- 4.6 years). MCI patients were assigned to receive either 7 months of training or standard care. After 7 months, both groups were reassessed for changes in LTL and the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog). Telomerase reverse transcriptase (hTERT) mRNA and telomeric repeat-containing RNA (TERRA) were also tested in 24 patients. Results MCI patients had shorter LTL than controls (p = 0.02), and short LTL was associated with a higher risk of MCI (ORadjusted = 2.6; 95%CI, 1.1-6.0; p = 0.03). Training improved ADAS-cog scores (T-0 = 15.1 +/- 4.8 to T-7 = 13.4 +/- 5.0, p = 0.01) and increased LTL (T-0 = 0.97 +/- 0.21 to T-7 = 1.04 +/- 0.23, p = 0.04). hTERT mRNA levels were negligible in MCI patients at T0 and T7, indicating inactive telomerase. TERRA expression increased in untrained MCI (p = 0.02), which may reflect impaired telomere homeostasis. Conclusions MCI patients have shorter telomeres, and combined training lengthens them, suggesting modifiable telomere homeostasis through non-pharmacological intervention. Telomere shortening may underlie increased telomeric transcription in untrained individuals, highlighting telomeric non-coding RNAs as potential therapeutic targets in age-related disease.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


